Incremental Value of Global Longitudinal Strain for Predicting Survival in Patients With Advanced AL Amyloidosis
Background: Advanced light-chain (AL) amyloidosis is associated with poor prognosis, with a 5-year survival rate of <25%. Prognostication is based on the revised Mayo (rMayo) staging according to serum cardiac biomarkers. Objectives: This study sought to determine whether global longitudinal stra...
Main Authors: | Katherine Lee Chuy, MD, Esther Drill, DrPH, Ji Can Yang, DO, Heather Landau, MD, Hani Hassoun, MD, Omar Nahhas, MD, Carol L. Chen, MD, Anthony F. Yu, MD, Richard M. Steingart, MD, Jennifer E. Liu, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-06-01
|
Series: | JACC. CardioOncology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666087320300946 |
Similar Items
-
Evidence of Concurrent Light Chain and Transthyretin Cardiac Amyloidosis in 2 Patients
by: Joseph P. Donnelly, MD, et al.
Published: (2020-03-01) -
Evaluating Prognosis in AL Amyloidosis
by: Rodney H. Falk, MD, et al.
Published: (2020-06-01) -
Longitudinal Changes in Echocardiographic Parameters of Cardiac Function in Pediatric Cancer Survivors
by: William L. Border, MBChB, MPH, et al.
Published: (2020-03-01) -
Disease-Modifying Therapy for Transthyretin Amyloidosis
by: Nowell M. Fine, MD, SM
Published: (2020-11-01) -
Diagnosis and Screening of Patients with Hereditary Transthyretin Amyloidosis (hATTR): Current Strategies and Guidelines
by: Benson MD, et al.
Published: (2020-08-01)